Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danlu Capsule for hyperplasia of mammary gland (Phase IV, single‑arm, open-label)
ChiCTR2000035230Phase 4Completed
- Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Danlu Capsule in breast hyperplasia, sponsored by Xiyuan Hospital of China Academy of Chinese Medical Sciences. Primary endpoints: Breast pain, Breast tumor size and 2 more. Started Jan 2018; status: completed.
02
Drugs
Danlu Capsule
03
Conditions
breast hyperplasia
Beyond the preview
Go deeper on ChiCTR2000035230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035230.